| Date Filed | Type | Description |
| 10/10/2023 |
8-K
| Quarterly results |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/14/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/02/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
8-K
| Quarterly results |
| 05/18/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits Interactive Data |
| 05/04/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/03/2023 |
8-K
| Quarterly results |
| 04/28/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 04/18/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
8-K
| Quarterly results |
| 04/03/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/03/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/03/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 02/23/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/22/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/31/2023 |
8-K
| Quarterly results |
| 01/26/2023 |
SC 13G/A
| BlackRock Inc. reports a 16.4% stake in CROSS COUNTRY HEALTHCARE INC |
| 01/20/2023 |
SC 13G
| BlackRock Inc. reports a 16.4% stake in CROSS COUNTRY HEALTHCARE INC |
| 01/05/2023 |
8-K
| Appointed a new director |
| 12/16/2022 |
8-K
| Quarterly results |
| 11/21/2022 |
8-K
| Appointed a new director |
| 11/17/2022 |
8-K
| Quarterly results |
| 11/09/2022 |
8-K
| Quarterly results |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/02/2022 |
8-K
| Quarterly results |
| 10/28/2022 |
SC 13D/A
| Simcoe Capital Management, LLC reports a 4.2% stake in Cross Country Healthcare, Inc. |
| 10/13/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 10/11/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 09/19/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|